The systematical review a functionality participation ingredient "psyllium" exerts on constipated improvement
- Conditions
- Clinical research conducted in healthy subjects not suffering from gastrointestinal and gastrointestinal diseases in Japan
- Registration Number
- JPRN-UMIN000026160
- Lead Sponsor
- Adaptgen Pharmaceutical Co., Ltd. Sales Planning Division & Clinical development division
- Brief Summary
By ingesting a food-derived functional involved component "psyllium", continuous ingestion of RQ / CQ "food-derived functional component psyllium" defined in this SR research review improved constipation compared with the control group Do you let it? "The continuous use of psyllium improves the frequency of defecation, the number of days of defecation, the amount of defecation and improves constipation tendency", and "usage, dosage" confirmed efficacy and safety are as follows I came to the conclusion. 1. Effect to improve stool frequency (Direction) Once a day / 2 times / day / day (Dose) 4.0 g / day to 8.0 g / day per day 2. The effect of improving defecation days (Direction) Once a day / 2 times / day / day (Dose) 4.0 g / day to 8.0 g / day per day 3. Effect to improve defecation volume (Direction) Once a day / 2 times / day / day (Dose) 4.0 g / day to 8.0 g / day per day
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1
Not provided
[Exclusion Criteria] In the secondary screening, provisional candidate documents are obtained by the abstract, and those corresponding to one or more of the following exclusion criteria are excluded from the candidate literature. 1.Clinical research literature for subjects suffering from gastrointestinal and gastrointestinal diseases 2.Clinical research literature for minors 3.Literature of clinical research for pregnant women and lactating women 4.Clinical research literature not reviewed 5.Literature of clinical study without comparative control group 6.Clinical research literature in which the main involved component is not psylium 7.Clinical research literature which can not be evaluated by glucosylceramide and other equivalent ingredients 8.In addition, clinical research literature judged inappropriate by the reviewer's agreement
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method